DCH
Dauch Corporation
DCH has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over DCH overall, supported by stronger fundamentals and stronger modeled upside.
DCH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
DCH's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
DCH PE Valuation
DCH has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
DCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DCH, with profitability improving. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | — |
| Q3 2026 | -$1.33 | -491% |
| Q2 2026 | -$1.07 | -406% |
| Q1 2026 | -$0.75 | -517% |
| Q4 2025 | -$0.17 | -159% |
| Q3 2025 | $0.34 | +48% |
| Q2 2025 | $0.35 | +$0.35 |
| Q1 2025 | $0.18 | +$0.26 |
| Q4 2024 | $0.29 | +$0.58 |
DCH has swung to a loss: it lost $1.33 per share over the past year, after a profit the year before.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
DCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.9B | +93% |
| Q2 2026 | $3B | +92% |
| Q1 2026 | $2.4B | +69% |
| Q4 2025 | $1.4B | +0.2% |
| Q3 2025 | $1.5B | 0% |
| Q2 2025 | $1.5B | -5.9% |
| Q1 2025 | $1.4B | -12% |
| Q4 2024 | $1.4B | -5.6% |
DCH's revenue has grown year over year for five quarters in a row: $2.9B last quarter, up 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.5% | -0.8 points |
| Q2 2026 | 3.4% | -0.2 points |
| Q1 2026 | -1.4% | -4.4 points |
| Q4 2025 | -2.4% | -5.1 points |
| Q3 2025 | 3.2% | +0.5 points |
| Q2 2025 | 3.6% | -1.7 points |
| Q1 2025 | 3% | -1.8 points |
| Q4 2024 | 2.6% | +0.7 points |
DCH has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over DCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
DCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $54.7M | -31% |
| Q2 2026 | $9.2M | -73% |
| Q1 2026 | -$168M | -$154.6M |
| Q4 2025 | $54.7M | -25% |
| Q3 2025 | $79.2M | +13% |
| Q2 2025 | $34.6M | -63% |
| Q1 2025 | -$13.4M | +$16.8M |
| Q4 2024 | $73.2M | +$76.3M |
DCH's free cash flow has turned negative after years in the green: −$49M over the past year.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
DCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.0x | High |
| Q2 2026 | 6.0x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 3.0x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.0x | Moderate |
DCH's net debt is about 5.0 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 7.8 | Oversold |
DCH's weekly RSI is 39 (neutral) and its Stochastic is 8 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
DCH PE vs Industrials Sector
| Metric | DCH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DCH has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
DCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.02 | 7.4% below |
| 20 week MA | $5.63 | 17% below |
| 50 week MA | $6.16 | 25% below |
| 100 week MA | $5.63 | 17% below |
| 200 week MA | $6.52 | 29% below |
DCH is in a downtrend: it's below all five of its weekly moving averages, and 29% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over DCH on trend strength, trading above more of its moving averages.
DCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.6 | $8.23 | -23% |
| 2021 | $8.23 | $9.34 | +13% |
| 2022 | $9.34 | $7.65 | -18% |
| 2023 | $7.65 | $8.81 | +15% |
| 2024 | $8.81 | $5.86 | -33% |
| 2025 | $5.86 | $6.46 | +10% |
| 2026 YTD | $6.46 | $4.65 | -28% |
DCH has finished lower in three of the last six years. It's down 28% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over DCH on returns for 2026, with the stronger performance.